Evidence map›Paper›PMID 32781177›Full record

ReviewJournal of the American Academy of Dermatology2021

Restorative oncodermatology: Diagnosis and management of dermatologic sequelae from cancer therapies.

Anthony M Rossi, Brian P Hibler, Cristian Navarrete-Dechent, Mario E Lacouture

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the American Academy of Dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Perspectives on managing skin manifestations in cancer patients: a multidisciplinary mixed-method survey of oncologists and dermatologists.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Clinical presentations of skin of color in oncodermatology.Journal of the American Academy of Dermatology · 2025
    Article
  10. Article
  11. Article
  12. Cosmetic considerations after breast cancer treatment.Archives of dermatological research · 2024
    Review
  13. Article
  14. Article
  15. Shedding light on the management of acute radiation dermatitis: insight from the MASCC Oncodermatology study group.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  16. Article
  17. Current quality of life assessment tools may not fully address dermatological adverse events from anti-cancer therapies.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Review
  18. Article
  19. Article
  20. Supportive oncodermatology-a narrative review of its utility and the way forward.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Anthony M RossiDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: rossia@mskcc.org.
Brian P HiblerDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Weill Cornell Medicine, New York, New York.
Cristian Navarrete-DechentDepartment of Dermatology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Mario E LacoutureDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Weill Cornell Medicine, New York, New York.
Cornell University · USPontificia Universidad Católica de Chile · CLWeill Cornell Medicine · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The long-term survival of patients with cancer has risen dramatically during the last few decades. Despite this remarkable success, the same treatments that have enabled cure or remission often secondarily affect the skin, hair, and nails. Conditions including scarring, striae distensae, persistent alopecia, pigmentary changes, nail alterations, chronic radiation dermatitis, and radiation fibrosis have been associated with anxiety, depression, decreased quality of life, and impaired function. These dermatologic changes are cosmetically disfiguring, may limit activities, and are a visual reminder of past illness. Interventions toward improving these untoward sequelae and restoring the appearance and function of skin and appendages are critical for normalization and may contribute to improved quality of life in cancer survivors. Here, we outline dermatologic sequelae of cancer therapies with a review of medical and procedural treatment strategies to restore dermatologic health in the survivorship population.

Indexed as

NeoplasmsQuality of LifeAlopeciaHumansRadiation Fibrosis SyndromeSkinalopeciacancercancer survivorschemotherapydermal fillershyperpigmentationhypopigmentationlymphedemaneuromodulatorsquality of liferadiationreconstructionscarstriaesurgerytelangiectasias

Identifiers

PMID32781177
PMCPMC7868476
OpenAlexW3048062915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.